Activity

Benefit-risk evaluation in drug licensing decisions: current European status

Activity: Talk or presentationProfessional

Hans Hillege - Speaker

Presentation/workshop during SIR European Regulatory Affairs (ERA) course
17-Jan-2018

External organisation

NameSIR Institute for Pharmacy Practice and Policy
CityLeiden
CountryNetherlands

ID: 79170321